Pharmidex at Advanced Therapies Integrates 2024!
December 2, 2024
Ash Alavijeh and
Janette Dalay Robertson, were thrilled to attend the dynamic and insightful conference. The sessions were packed with thought-provoking discussions.
Special thanks to the organisers at Life Science Integrates,
Cell and Gene Therapy Catapult and
GSK for creating such a fantastic space to connect and share ideas.
Oh, and a fun side note:
Janette Dalay Robertson might have spent a bit too much time experimenting with the Virtual Reality glasses! 🕶️ Let’s just say She's ready for the metaverse now. 😉
Looking forward to continuing the conversations we started and exploring potential collaborations with some of the amazing people we met!
#AdvancedTherapiesIntegrates #Networking #Innovation #Pharmidex #catapultcellandgenetherapy #GSK
We’re excited to welcome Grace Horne as our new Bioanalytical Scientist! 🎉 Grace brings great enthusiasm and passion for science, and we’re confident she’ll make a fantastic contribution to our team. Welcome aboard, Grace, we’re thrilled to have you with us! 💜
We’re pleased to share that Janette Dalay Robertson , Business Development Manager at Pharmidex , will attend the DDW Turning Science into Business Symposium 2025 on Tuesday, 4th November, at the The Francis Crick Institute , London. Janette looks forward to connecting with industry leaders and exploring new collaboration opportunities.
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
